Featured Research

from universities, journals, and other organizations

Twelve new epilepsy drugs usher in 'era of abundance'

Date:
October 21, 2010
Source:
Loyola University Health System
Summary:
A dozen new epilepsy drugs are giving doctors and patients more options, but making treatment decisions more complex, a epilepsy specialist reports.

A dozen new epilepsy drugs are giving doctors and patients more options, but making treatment decisions more complex, a Loyola epilepsy specialist reports in the journal Neurologic Clinics.

Related Articles


"Clinicians practice in an era of abundance of anti-epileptic drugs," Dr. Jorge J. Asconapé wrote. The new drugs provide "an opportunity to better meet the needs of more patients."

Asconapé's article will appear in the November issue of Neurologic Clinics.

Since 1993, the Food and Drug Administration has approved 12 new anti-epileptic drugs: felbamate (brand name, Felbatol®) gabapentin (Neurotin®), lamotrigine (Lamictal®), lacosamide (Vimpat®), levetiracetam (Keppra®), oxcarbazepine (Trilepal®), pregabalin (Lyrica®), rufinamide (Banzel®), tiagabine (Gabitril®), topiramate (Topamax®), vigabatrin (Sabril®) and zonisamide (Zonegran®).

Epilepsy is one of the most common chronic neurologic conditions, affecting as many as 45 million people worldwide. Infants and the elderly are at the highest risk. About two-thirds of epilepsies are localized, meaning seizures involve part of one side of the brain. The other cases are generalized, involving both sides of the brain, Asconapé wrote.

Between 60 percent and 70 percent of patients have an adequate response to drugs. But a patient who does not benefit from two drugs in a row probably won't respond to any medication. For such patients, alternative treatments include special diet, behavioral modification, hormonal therapies, neurostimulation and immunotherapy.

Drugs are divided into two groups: narrow-spectrum, which are mostly effective in focal seizures, and broad spectrum, which work for both focal and generalized seizures.

"Pediatricians and primary-care physicians ought to consider using broad-spectrum drugs rather than drugs such as phenobarbital and phenytoin, especially in children and adolescents, given the high incidence of generalized epilepsy syndromes in these age groups," Asconapé wrote. Asconapé is a professor in the Department of Neurology at Loyola University Chicago Stritch School of Medicine.

The newer drugs generally do not work better than the older drugs. But the newer drugs are easier to use, with fewer adverse interactions when taken in combination with other drugs. The newer drugs also have expanded the availability of broad-spectrum medications. This is a "major benefit for patients with generalized epilepsies," Asconapé wrote.

The long list of anti-epileptic drugs has also benefited epilepsy patients who have other diseases or conditions. This often allows for the use of drugs that either help or at least have no negative effects on those conditions, Asconapé wrote.

Asconapé's review is among 15 articles in the November issue of Neurologic Clinics that detail latest advances in the treatment and management of epilepsy and other neurological disorders. Guest editor is Dr. José Biller, chairman of the Department of Neurology at Loyola University Chicago Stritch School of Medicine.

"Great therapeutic strides in the clinical neurosciences have been made in the past decades," Biller wrote in the preface to the November issue. "It is likely that subsequent decades will bring even greater advances in neurologically oriented therapies."


Story Source:

The above story is based on materials provided by Loyola University Health System. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jorge J. Asconap. The Selection of Antiepileptic Drugs for the Treatment of Epilepsy in Children and Adults. Neurologic Clinics, 2010; 28 (4): 843 DOI: 10.1016/j.ncl.2010.03.026

Cite This Page:

Loyola University Health System. "Twelve new epilepsy drugs usher in 'era of abundance'." ScienceDaily. ScienceDaily, 21 October 2010. <www.sciencedaily.com/releases/2010/10/101021103117.htm>.
Loyola University Health System. (2010, October 21). Twelve new epilepsy drugs usher in 'era of abundance'. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2010/10/101021103117.htm
Loyola University Health System. "Twelve new epilepsy drugs usher in 'era of abundance'." ScienceDaily. www.sciencedaily.com/releases/2010/10/101021103117.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Just A Half-Hour Of Lost Sleep Could Lead To Weight Gain

Just A Half-Hour Of Lost Sleep Could Lead To Weight Gain

Newsy (Mar. 6, 2015) — A new study found losing just half an hour of sleep could make you gain weight. Video provided by Newsy
Powered by NewsLook.com
Suicide Rates Up For Young Women In U.S.

Suicide Rates Up For Young Women In U.S.

Newsy (Mar. 6, 2015) — According to a report from the CDC, suicide rates among young women increased from 1994 to 2012 while rates among young men have decreased. Video provided by Newsy
Powered by NewsLook.com
Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) — Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Liberia Releases Last Ebola Patient, But Threat Remains

Liberia Releases Last Ebola Patient, But Threat Remains

Newsy (Mar. 5, 2015) — Liberia&apos;s last Ebola patient has been released, and the country hasn&apos;t recorded a new case in a week. However, fears of another outbreak still exist. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins